It is a drug formulated by Hoffmann-La Roche which functions for a potent and selective unfavorable allosteric modulator for group II from the metabotropic glutamate receptors (mGluR2/3), remaining equipotent at mGluR2 and mGluR3 but with no exercise at other mGluR subtypes.Prior to getting VOQUEZNA, inform your healthcare company about your health